Clinical Characteristics and Specialized Nursing Management of HIV-Positive Patients Undergoing Chemotherapy: A Study Based on 44 Cases from 2020 to 2024
Objective: To systematically analyze the clinical characteristics and nursing management effects of chemotherapy patients in the Obstetrics and Gynecology Ward of Nanning Fourth People’s Hospital from 2020 to 2024, and to provide a 5-year long-term evidence-based basis for optimizing specialized nursing programs for gynecological cancer patients undergoing chemotherapy. Methods: A retrospective analysis was conducted to collect complete clinical data of 44 chemotherapy patients admitted to the Obstetrics and Gynecology Ward of the hospital from January 2020 to December 2024. Indicators such as patient age, diagnosis type, length of hospital stay, treatment effect, antibiotic use, and discharge outcome were analyzed by annual stratification to evaluate the long-term stability of nursing management quality. Results: All 44 patients were female (100%), aged 24 - 70 years with an average of (48.8 ± 9.7) years, and the proportion of patients aged 41 - 50 years was the highest (31.8%, 14/44); the number of annual cases showed a fluctuating upward trend (9 cases in 2020 →14 cases in 2022 →8 cases in 2024); the main diagnosis was maintenance chemotherapy for malignant tumors (43.2%, 19/44), with a stable annual proportion; the average length of hospital stay decreased year by year from 7.9 days in 2020 to 6.3 days in 2024; the total 5-year treatment effective rate was 78.0% (32/41), the antibiotic use rate was controlled at 31.8% (14/44), the normal discharge rate reached 95.5% (42/44), and there was no significant annual fluctuation. Conclusion: From 2020 to 2024, chemotherapy patients in the Obstetrics and Gynecology Ward were mainly middle-aged women receiving maintenance treatment for malignant tumors, with a steadily growing case scale. Nursing management has achieved remarkable results in ensuring treatment effect, improving hospitalization efficiency, and standardizing antibiotic use, with good long-term stability. It can provide a reference for the continuous improvement of specialized nursing quality.
References
[1]
Shiels, M.S., Pfeiffer, R.M., Gail, M.H., Hall, H.I., et al. (2021) Cancer Burden in the HIV-Infected Population in the United States. Journal of the National Cancer Institute, 113, 789-797.
[2]
Strickler, H.D., Sherrill, K.M., Wentzensen, N.,et al. (2023) Primary HPV and Cervical Cancer Screening in HIV-Positive Women. AIDS, 37, 265-274.
[3]
Uldrick, T.S., Yarchoan, R., Pittaluga, S., et al. (2022) Modern Approaches to HIV-Associated Cancer. Journal of Clinical Oncology, 40, 277-290.
[4]
Zhang, Y., Li, X., Wang, Y., et al. (2023) Clinical Characteristics and Prognosis of HIV-Positive Gynecological Cancer Patients in China. Chinese Medical Journal, 136, 956-962.
[5]
Chinese Medical Association Society of Infectious Diseases (2021) Guidelines for the Diagnosis and Treatment of AIDS (2021 Edition). Chinese Journal of Infectious Diseases, 39, 1-33.
[6]
Johnson, L.F., Ostrowski, S.R., Saint, S., et al. (2022) Infection Prevention Strategies in HIV-Positive Oncology Patients: A Randomized Controlled Trial. Infection Control & Hospital Epidemiology, 43, 612-618.
[7]
Wang, X.H. and Li, L.Z. (2022) Oncology Nursing. 5th Edition, People’s Medical Publishing House.
[8]
Li, L.J. and Wang, Y.M. (2018) Infectious Diseases. 9th Edition, People’s Medical Publishing House.
[9]
Rudek, M.A., Kurzrock, R., Wainberg, M.A., et al. (2021) Pharmacology of Antineoplastic Drugs in Patients with HIV Infection. Oncologist, 26, e1-e10.
[10]
Parums, D.V. (2023) Multidisciplinary Team (MDT) in Oncology and the Pivotal Role of Specialized Nursing. Medical Science Monitor, 29, e940123.
[11]
Smith, C.J., Cusack, C., Hegney, D., et al. (2022) Nursing Interventions for HIV-Positive Cancer Patients Undergoing Chemotherapy: A Systematic Review. The Journal of Advanced Nursing, 78, 1234-1246.
[12]
Clifford, G.M., Casper, C., Engels, E.A., et al. (2022) HIV and the Risk of Cancers Associated with Viral Infections. The Lancet Oncology, 23, e200-e210.
[13]
Bower, M., Newton, R., Gazzard, B., et al. (2022) British HIV Association Guidelines for the Management of HIV-Associated Malignancies 2022. HIV Medicines, 23, 3-89.
[14]
World Health Organization (2021) Guidelines for the Management of Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy.
[15]
Brown, A.E., Florez, A.B., Sigel, K., et al. (2023) Long-Term Outcomes of HIV-Associated Gynecological Cancers: A Cohort Study. Cancer, 129, 2015-2024.
